Epitope tags: Explained
IPI epitope tag antibodies, delivered via an open science model, aim to increase access, cut…
IPI’s community-centered approach to antibody discovery: A Q&A with Rob Meijers
This spring, the Institute for Protein Innovation (IPI) dispatched a collection of antibodies targeting members…
Debora Marks at IPI: Generative models for prediction and design
Debora Marks gave a seminar at IPI on March 21, 2024. She spoke about her…
Cell signaling, Sonic Hedgehog and Hemingway’s cats: A Q&A with Adrian Salic
In 1980, the famous geneticists Christiane Nüsslein-Volhard and Eric Wieschaus were mapping embryonic mutations in…
IPI antibody helps illuminate the MYCN-mediated tumor microenvironment
If you were diagnosed with aggressive neuroblastoma, you’d most likely be an infant carrying a…
“A wise man always keeps learning”: Biotech entrepreneur Rusty Williams joins IPI Board
In 1984, Lewis “Rusty” Williams boarded a flight from Boston to San Francisco and took…
Engineering for efficiency: André Teixeira takes charge of antibody discovery and library design at IPI
It’s a few minutes after noon, and scientists at the Institute for Protein Innovation (IPI)…
Entry points into neuroscience: A Q&A with Thomas Biederer
At the heart of all nervous system functions are the synapses, where signals fly between…
At Cell Bio 2023, a multidisciplinary panel suggests solutions for antibody validation
Antibodies are among biologists’ most essential tools, but many just don’t work. Worse, many researchers…
For IPI Board member Auro Nair, biotech is an outlet for good
Growing up in Malaysia, Auro Nair learned two basic tenets from his parents: Be a…
Dissecting the nervous system’s self-assembly toolkit: A Q&A with Alex Jaworski
Early in development, an embryo begins an epic undertaking: the building of its nervous system…
IPI cell surface receptor research and the opioid crisis
Cell surface receptors are the root cause of a number of illnesses, and the target…